Larvol Delta - Pyxis-Oncology-Announces-Positive-Updated-Data-from-Phase-1-Monotherapy-Study-of-Micvotabart-Pelidotin-MICVO-in-SecondLine-and-Beyond-RecurrentMetastatic-Head-and-Neck-Squamous-Cell-Carcinoma

Koselugo (selumetinib) - AstraZeneca

https://virtual.oxfordabstracts.com/event/76734/session/223371

Trishla Gandhi; Sean Grimm

Sep 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next